Saadia supports biotech and pharma companies at critical growth junctures. Areas she advises in include program prioritization and go/no go decisions, disease area and indication prioritization, partnering strategy.
Her experience includes technical and commercial assessment/due diligence of therapeutics, out-licensing, technology scouting/in-licensing, asset valuations, therapeutic area strategy and product development strategy.
Saadia holds an Honours degree in Biomedical Informatics, a Master of Science degree in Molecular Medicine and a PhD in Neuroendocrinology from Imperial College.
Opportunity mapping
In-licensing & Asset scouting
Out-licensing, Partnering & Deal-making
Clinical development strategy & Clinical development services
Due diligence
Asset valuations
BACK
Contact us today to learn how our pharma & biotech consulting expertise can serve your project.
Contact us© 2023 Alacrita Holdings Limited | Pharma & Biotech Consulting
Alacrita Life Science Consulting
2 Royal College St
London, UK
NW1 0NH
Registered in England & Wales.
No. 10530608
One Broadway
Floor 14
Cambridge, MA 02142
Registered in Massachusetts.